Global Age Related Macular Degeneration (AMD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Age Related Macular Degeneration (AMD) market size was valued at USD 7949.4 million in 2023 and is forecast to a readjusted size of USD 11600 million by 2030 with a CAGR of 5.6% during review period.

Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.

The Global Info Research report includes an overview of the development of the Age Related Macular Degeneration (AMD) industry chain, the market status of Men (Wet AMD, Dry AMD), Woman (Wet AMD, Dry AMD), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Age Related Macular Degeneration (AMD).

Regionally, the report analyzes the Age Related Macular Degeneration (AMD) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Age Related Macular Degeneration (AMD) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Age Related Macular Degeneration (AMD) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Age Related Macular Degeneration (AMD) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Wet AMD, Dry AMD).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Age Related Macular Degeneration (AMD) market.

Regional Analysis: The report involves examining the Age Related Macular Degeneration (AMD) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Age Related Macular Degeneration (AMD) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Age Related Macular Degeneration (AMD):
Company Analysis: Report covers individual Age Related Macular Degeneration (AMD) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Age Related Macular Degeneration (AMD) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Men, Woman).

Technology Analysis: Report covers specific technologies relevant to Age Related Macular Degeneration (AMD). It assesses the current state, advancements, and potential future developments in Age Related Macular Degeneration (AMD) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Age Related Macular Degeneration (AMD) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Age Related Macular Degeneration (AMD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Wet AMD
    Dry AMD

Market segment by Application
    Men
    Woman

Market segment by players, this report covers
    Bayer
    F. HoffmannLa Roche
    Regeneron
    Novartis
    Valeant
    Pfizer

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Age Related Macular Degeneration (AMD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Age Related Macular Degeneration (AMD), with revenue, gross margin and global market share of Age Related Macular Degeneration (AMD) from 2019 to 2024.
Chapter 3, the Age Related Macular Degeneration (AMD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Age Related Macular Degeneration (AMD) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Age Related Macular Degeneration (AMD).
Chapter 13, to describe Age Related Macular Degeneration (AMD) research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Age Related Macular Degeneration (AMD)
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Age Related Macular Degeneration (AMD) by Type
        1.3.1 Overview: Global Age Related Macular Degeneration (AMD) Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Age Related Macular Degeneration (AMD) Consumption Value Market Share by Type in 2023
        1.3.3 Wet AMD
        1.3.4 Dry AMD
    1.4 Global Age Related Macular Degeneration (AMD) Market by Application
        1.4.1 Overview: Global Age Related Macular Degeneration (AMD) Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Men
        1.4.3 Woman
    1.5 Global Age Related Macular Degeneration (AMD) Market Size & Forecast
    1.6 Global Age Related Macular Degeneration (AMD) Market Size and Forecast by Region
        1.6.1 Global Age Related Macular Degeneration (AMD) Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Age Related Macular Degeneration (AMD) Market Size by Region, (2019-2030)
        1.6.3 North America Age Related Macular Degeneration (AMD) Market Size and Prospect (2019-2030)
        1.6.4 Europe Age Related Macular Degeneration (AMD) Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size and Prospect (2019-2030)
        1.6.6 South America Age Related Macular Degeneration (AMD) Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Age Related Macular Degeneration (AMD) Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Age Related Macular Degeneration (AMD) Product and Solutions
        2.1.4 Bayer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bayer Recent Developments and Future Plans
    2.2 F. HoffmannLa Roche
        2.2.1 F. HoffmannLa Roche Details
        2.2.2 F. HoffmannLa Roche Major Business
        2.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product and Solutions
        2.2.4 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 F. HoffmannLa Roche Recent Developments and Future Plans
    2.3 Regeneron
        2.3.1 Regeneron Details
        2.3.2 Regeneron Major Business
        2.3.3 Regeneron Age Related Macular Degeneration (AMD) Product and Solutions
        2.3.4 Regeneron Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Regeneron Recent Developments and Future Plans
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis Age Related Macular Degeneration (AMD) Product and Solutions
        2.4.4 Novartis Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Novartis Recent Developments and Future Plans
    2.5 Valeant
        2.5.1 Valeant Details
        2.5.2 Valeant Major Business
        2.5.3 Valeant Age Related Macular Degeneration (AMD) Product and Solutions
        2.5.4 Valeant Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Valeant Recent Developments and Future Plans
    2.6 Pfizer
        2.6.1 Pfizer Details
        2.6.2 Pfizer Major Business
        2.6.3 Pfizer Age Related Macular Degeneration (AMD) Product and Solutions
        2.6.4 Pfizer Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Pfizer Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Age Related Macular Degeneration (AMD) Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Age Related Macular Degeneration (AMD) by Company Revenue
        3.2.2 Top 3 Age Related Macular Degeneration (AMD) Players Market Share in 2023
        3.2.3 Top 6 Age Related Macular Degeneration (AMD) Players Market Share in 2023
    3.3 Age Related Macular Degeneration (AMD) Market: Overall Company Footprint Analysis
        3.3.1 Age Related Macular Degeneration (AMD) Market: Region Footprint
        3.3.2 Age Related Macular Degeneration (AMD) Market: Company Product Type Footprint
        3.3.3 Age Related Macular Degeneration (AMD) Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Age Related Macular Degeneration (AMD) Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Age Related Macular Degeneration (AMD) Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Age Related Macular Degeneration (AMD) Consumption Value Market Share by Application (2019-2024)
    5.2 Global Age Related Macular Degeneration (AMD) Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Age Related Macular Degeneration (AMD) Consumption Value by Type (2019-2030)
    6.2 North America Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2030)
    6.3 North America Age Related Macular Degeneration (AMD) Market Size by Country
        6.3.1 North America Age Related Macular Degeneration (AMD) Consumption Value by Country (2019-2030)
        6.3.2 United States Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        6.3.3 Canada Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        6.3.4 Mexico Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Age Related Macular Degeneration (AMD) Consumption Value by Type (2019-2030)
    7.2 Europe Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2030)
    7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Country
        7.3.1 Europe Age Related Macular Degeneration (AMD) Consumption Value by Country (2019-2030)
        7.3.2 Germany Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        7.3.3 France Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        7.3.5 Russia Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        7.3.6 Italy Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region
        8.3.1 Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value by Region (2019-2030)
        8.3.2 China Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        8.3.3 Japan Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        8.3.4 South Korea Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        8.3.5 India Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        8.3.7 Australia Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Age Related Macular Degeneration (AMD) Consumption Value by Type (2019-2030)
    9.2 South America Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2030)
    9.3 South America Age Related Macular Degeneration (AMD) Market Size by Country
        9.3.1 South America Age Related Macular Degeneration (AMD) Consumption Value by Country (2019-2030)
        9.3.2 Brazil Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        9.3.3 Argentina Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Age Related Macular Degeneration (AMD) Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country
        10.3.1 Middle East & Africa Age Related Macular Degeneration (AMD) Consumption Value by Country (2019-2030)
        10.3.2 Turkey Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)
        10.3.4 UAE Age Related Macular Degeneration (AMD) Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Age Related Macular Degeneration (AMD) Market Drivers
    11.2 Age Related Macular Degeneration (AMD) Market Restraints
    11.3 Age Related Macular Degeneration (AMD) Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Age Related Macular Degeneration (AMD) Industry Chain
    12.2 Age Related Macular Degeneration (AMD) Upstream Analysis
    12.3 Age Related Macular Degeneration (AMD) Midstream Analysis
    12.4 Age Related Macular Degeneration (AMD) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Age Related Macular Degeneration (AMD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Age Related Macular Degeneration (AMD) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Age Related Macular Degeneration (AMD) Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Age Related Macular Degeneration (AMD) Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Bayer Company Information, Head Office, and Major Competitors
    Table 6. Bayer Major Business
    Table 7. Bayer Age Related Macular Degeneration (AMD) Product and Solutions
    Table 8. Bayer Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Bayer Recent Developments and Future Plans
    Table 10. F. HoffmannLa Roche Company Information, Head Office, and Major Competitors
    Table 11. F. HoffmannLa Roche Major Business
    Table 12. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product and Solutions
    Table 13. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. F. HoffmannLa Roche Recent Developments and Future Plans
    Table 15. Regeneron Company Information, Head Office, and Major Competitors
    Table 16. Regeneron Major Business
    Table 17. Regeneron Age Related Macular Degeneration (AMD) Product and Solutions
    Table 18. Regeneron Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Regeneron Recent Developments and Future Plans
    Table 20. Novartis Company Information, Head Office, and Major Competitors
    Table 21. Novartis Major Business
    Table 22. Novartis Age Related Macular Degeneration (AMD) Product and Solutions
    Table 23. Novartis Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Novartis Recent Developments and Future Plans
    Table 25. Valeant Company Information, Head Office, and Major Competitors
    Table 26. Valeant Major Business
    Table 27. Valeant Age Related Macular Degeneration (AMD) Product and Solutions
    Table 28. Valeant Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Valeant Recent Developments and Future Plans
    Table 30. Pfizer Company Information, Head Office, and Major Competitors
    Table 31. Pfizer Major Business
    Table 32. Pfizer Age Related Macular Degeneration (AMD) Product and Solutions
    Table 33. Pfizer Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Pfizer Recent Developments and Future Plans
    Table 35. Global Age Related Macular Degeneration (AMD) Revenue (USD Million) by Players (2019-2024)
    Table 36. Global Age Related Macular Degeneration (AMD) Revenue Share by Players (2019-2024)
    Table 37. Breakdown of Age Related Macular Degeneration (AMD) by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 38. Market Position of Players in Age Related Macular Degeneration (AMD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 39. Head Office of Key Age Related Macular Degeneration (AMD) Players
    Table 40. Age Related Macular Degeneration (AMD) Market: Company Product Type Footprint
    Table 41. Age Related Macular Degeneration (AMD) Market: Company Product Application Footprint
    Table 42. Age Related Macular Degeneration (AMD) New Market Entrants and Barriers to Market Entry
    Table 43. Age Related Macular Degeneration (AMD) Mergers, Acquisition, Agreements, and Collaborations
    Table 44. Global Age Related Macular Degeneration (AMD) Consumption Value (USD Million) by Type (2019-2024)
    Table 45. Global Age Related Macular Degeneration (AMD) Consumption Value Share by Type (2019-2024)
    Table 46. Global Age Related Macular Degeneration (AMD) Consumption Value Forecast by Type (2025-2030)
    Table 47. Global Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2024)
    Table 48. Global Age Related Macular Degeneration (AMD) Consumption Value Forecast by Application (2025-2030)
    Table 49. North America Age Related Macular Degeneration (AMD) Consumption Value by Type (2019-2024) & (USD Million)
    Table 50. North America Age Related Macular Degeneration (AMD) Consumption Value by Type (2025-2030) & (USD Million)
    Table 51. North America Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2024) & (USD Million)
    Table 52. North America Age Related Macular Degeneration (AMD) Consumption Value by Application (2025-2030) & (USD Million)
    Table 53. North America Age Related Macular Degeneration (AMD) Consumption Value by Country (2019-2024) & (USD Million)
    Table 54. North America Age Related Macular Degeneration (AMD) Consumption Value by Country (2025-2030) & (USD Million)
    Table 55. Europe Age Related Macular Degeneration (AMD) Consumption Value by Type (2019-2024) & (USD Million)
    Table 56. Europe Age Related Macular Degeneration (AMD) Consumption Value by Type (2025-2030) & (USD Million)
    Table 57. Europe Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2024) & (USD Million)
    Table 58. Europe Age Related Macular Degeneration (AMD) Consumption Value by Application (2025-2030) & (USD Million)
    Table 59. Europe Age Related Macular Degeneration (AMD) Consumption Value by Country (2019-2024) & (USD Million)
    Table 60. Europe Age Related Macular Degeneration (AMD) Consumption Value by Country (2025-2030) & (USD Million)
    Table 61. Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value by Type (2019-2024) & (USD Million)
    Table 62. Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value by Type (2025-2030) & (USD Million)
    Table 63. Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2024) & (USD Million)
    Table 64. Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value by Application (2025-2030) & (USD Million)
    Table 65. Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value by Region (2019-2024) & (USD Million)
    Table 66. Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value by Region (2025-2030) & (USD Million)
    Table 67. South America Age Related Macular Degeneration (AMD) Consumption Value by Type (2019-2024) & (USD Million)
    Table 68. South America Age Related Macular Degeneration (AMD) Consumption Value by Type (2025-2030) & (USD Million)
    Table 69. South America Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2024) & (USD Million)
    Table 70. South America Age Related Macular Degeneration (AMD) Consumption Value by Application (2025-2030) & (USD Million)
    Table 71. South America Age Related Macular Degeneration (AMD) Consumption Value by Country (2019-2024) & (USD Million)
    Table 72. South America Age Related Macular Degeneration (AMD) Consumption Value by Country (2025-2030) & (USD Million)
    Table 73. Middle East & Africa Age Related Macular Degeneration (AMD) Consumption Value by Type (2019-2024) & (USD Million)
    Table 74. Middle East & Africa Age Related Macular Degeneration (AMD) Consumption Value by Type (2025-2030) & (USD Million)
    Table 75. Middle East & Africa Age Related Macular Degeneration (AMD) Consumption Value by Application (2019-2024) & (USD Million)
    Table 76. Middle East & Africa Age Related Macular Degeneration (AMD) Consumption Value by Application (2025-2030) & (USD Million)
    Table 77. Middle East & Africa Age Related Macular Degeneration (AMD) Consumption Value by Country (2019-2024) & (USD Million)
    Table 78. Middle East & Africa Age Related Macular Degeneration (AMD) Consumption Value by Country (2025-2030) & (USD Million)
    Table 79. Age Related Macular Degeneration (AMD) Raw Material
    Table 80. Key Suppliers of Age Related Macular Degeneration (AMD) Raw Materials
List of Figures
    Figure 1. Age Related Macular Degeneration (AMD) Picture
    Figure 2. Global Age Related Macular Degeneration (AMD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Age Related Macular Degeneration (AMD) Consumption Value Market Share by Type in 2023
    Figure 4. Wet AMD
    Figure 5. Dry AMD
    Figure 6. Global Age Related Macular Degeneration (AMD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Age Related Macular Degeneration (AMD) Consumption Value Market Share by Application in 2023
    Figure 8. Men Picture
    Figure 9. Woman Picture
    Figure 10. Global Age Related Macular Degeneration (AMD) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Age Related Macular Degeneration (AMD) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Market Age Related Macular Degeneration (AMD) Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 13. Global Age Related Macular Degeneration (AMD) Consumption Value Market Share by Region (2019-2030)
    Figure 14. Global Age Related Macular Degeneration (AMD) Consumption Value Market Share by Region in 2023
    Figure 15. North America Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 16. Europe Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 17. Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 18. South America Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 19. Middle East and Africa Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 20. Global Age Related Macular Degeneration (AMD) Revenue Share by Players in 2023
    Figure 21. Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 22. Global Top 3 Players Age Related Macular Degeneration (AMD) Market Share in 2023
    Figure 23. Global Top 6 Players Age Related Macular Degeneration (AMD) Market Share in 2023
    Figure 24. Global Age Related Macular Degeneration (AMD) Consumption Value Share by Type (2019-2024)
    Figure 25. Global Age Related Macular Degeneration (AMD) Market Share Forecast by Type (2025-2030)
    Figure 26. Global Age Related Macular Degeneration (AMD) Consumption Value Share by Application (2019-2024)
    Figure 27. Global Age Related Macular Degeneration (AMD) Market Share Forecast by Application (2025-2030)
    Figure 28. North America Age Related Macular Degeneration (AMD) Consumption Value Market Share by Type (2019-2030)
    Figure 29. North America Age Related Macular Degeneration (AMD) Consumption Value Market Share by Application (2019-2030)
    Figure 30. North America Age Related Macular Degeneration (AMD) Consumption Value Market Share by Country (2019-2030)
    Figure 31. United States Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 32. Canada Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 33. Mexico Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 34. Europe Age Related Macular Degeneration (AMD) Consumption Value Market Share by Type (2019-2030)
    Figure 35. Europe Age Related Macular Degeneration (AMD) Consumption Value Market Share by Application (2019-2030)
    Figure 36. Europe Age Related Macular Degeneration (AMD) Consumption Value Market Share by Country (2019-2030)
    Figure 37. Germany Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 38. France Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 39. United Kingdom Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 40. Russia Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 41. Italy Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 42. Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value Market Share by Type (2019-2030)
    Figure 43. Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value Market Share by Application (2019-2030)
    Figure 44. Asia-Pacific Age Related Macular Degeneration (AMD) Consumption Value Market Share by Region (2019-2030)
    Figure 45. China Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 46. Japan Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 47. South Korea Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 48. India Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 49. Southeast Asia Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 50. Australia Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 51. South America Age Related Macular Degeneration (AMD) Consumption Value Market Share by Type (2019-2030)
    Figure 52. South America Age Related Macular Degeneration (AMD) Consumption Value Market Share by Application (2019-2030)
    Figure 53. South America Age Related Macular Degeneration (AMD) Consumption Value Market Share by Country (2019-2030)
    Figure 54. Brazil Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 55. Argentina Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 56. Middle East and Africa Age Related Macular Degeneration (AMD) Consumption Value Market Share by Type (2019-2030)
    Figure 57. Middle East and Africa Age Related Macular Degeneration (AMD) Consumption Value Market Share by Application (2019-2030)
    Figure 58. Middle East and Africa Age Related Macular Degeneration (AMD) Consumption Value Market Share by Country (2019-2030)
    Figure 59. Turkey Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 60. Saudi Arabia Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 61. UAE Age Related Macular Degeneration (AMD) Consumption Value (2019-2030) & (USD Million)
    Figure 62. Age Related Macular Degeneration (AMD) Market Drivers
    Figure 63. Age Related Macular Degeneration (AMD) Market Restraints
    Figure 64. Age Related Macular Degeneration (AMD) Market Trends
    Figure 65. Porters Five Forces Analysis
    Figure 66. Manufacturing Cost Structure Analysis of Age Related Macular Degeneration (AMD) in 2023
    Figure 67. Manufacturing Process Analysis of Age Related Macular Degeneration (AMD)
    Figure 68. Age Related Macular Degeneration (AMD) Industrial Chain
    Figure 69. Methodology
    Figure 70. Research Process and Data Source

Companies Mentioned

Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer